Difference between revisions of "Citalopram-mirtazapine"

From Psychiatrienet
Jump to: navigation, search
Line 2: Line 2:
 
| from = citalopram  
 
| from = citalopram  
 
| to = mirtazapine  
 
| to = mirtazapine  
| stop =  
+
| stop = {{StopCitalopram}}
* '''Before day 1:''' gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
 
* '''Day 1:''' reduce dosage of citalopram/escitalopram to a maximum of 10 mg/ day resp. 5 mg/day.
 
 
| start =  
 
| start =  
 
* '''Day 1:''' simultaneously start mirtazapine in a normal dosage of 15-30 mg/day.
 
* '''Day 1:''' simultaneously start mirtazapine in a normal dosage of 15-30 mg/day.
* '''Day 8:''' stop administration of citalopram/escitalopram and continue administration of mirtazapine.
+
* '''Day 8:''' stop administration of citalopram and continue administration of mirtazapine.
 
| info =  
 
| info =  
* The same applies to [[escitalopram]].
 
 
}}
 
}}

Revision as of 21:35, 4 March 2010

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Mirtazapine
Type Antidepressant
Group other
links
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine

Switch medication from citalopram to mirtazapine.[1] [2]

Nietinrijdenbord.png Stop citalopram
  • Before day 1: gradually reduce dosage of citalopram to a maximum of 20 mg/day, when this dosage is > 20 mg/day.
  • Day 1: reduce dosage of citalopram to a maximum of 10 mg/day.
  • Day 8: stop administration of citalopram
Eenrichtingbord.png Start mirtazapine
  • Day 1: simultaneously start mirtazapine in a normal dosage of 15-30 mg/day.
  • Day 8: stop administration of citalopram and continue administration of mirtazapine.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.